Tim Walbert is the founder of Horizon Therapeutics. Latest round: IPO. Based in Deerfield, United States.
Timothy Walbert is a Senior Advisor to Patient Square Capital and Managing Partner of HRZN Partners LLC. He was Chairman, President, and CEO of Horizon Therapeutics, growing it to approximately $4 billion in annual sales before its $28.3 billion acquisition by Amgen in 2023. Previously, he led IDM Pharma Inc. through its acquisition and held senior roles at Abbott, G.D. Searle & Company, Merck & Co., and Wyeth.
Full founder directory · Investor directory · Company funding database · Fundraising library